Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.285NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.285NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.582NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.582NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.582NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.580NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.580NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.580NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.306NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.306NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.306NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.280NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.280NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.280NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.329NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.329NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.329NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.396NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.396NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.396NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.595.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.595.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.595.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.311NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.311NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.311NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.369NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.369NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.369NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.367NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.367NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.367NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.595NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.595NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.595NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.240NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.240NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.240NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DL.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DL.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.15NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.529 (Omicron)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used